Template:Antidepressants: Difference between revisions

Revision as of 04:36, 28 April 2012 view sourceVanished 45kd09la13 (talk \| contribs)26,505 editsNo edit summary← Previous edit		Revision as of 19:51, 19 May 2012 view source Vanished 45kd09la13 (talk \| contribs)26,505 editsNo edit summaryNext edit →
Line 22:		Line 22:
	* ]		* ]
	* ]		* ]
			* ]
	* ]		* ]
	* ]		* ]

Revision as of 19:51, 19 May 2012

Specific reuptake inhibitors (RIs), enhancers (REs), and releasing agents (RAs)
Template:Navbox subgroup

Receptor antagonists and/or reuptake inhibitors
Template:Navbox subgroup

Heterocyclic antidepressants (bi-, tri-, and tetracyclics)
Template:Navbox subgroup

Monoamine oxidase inhibitors (MAOIs)
Template:Navbox subgroup

Azapirones and other 5-HT_1A receptor agonists
Alnespirone Aripiprazole Befiradol Buspirone Eptapirone Flesinoxan Flibanserin Gepirone Ipsapirone Oxaflozane Tandospirone Vilazodone Zalospirone

v t e Index of psychology and psychiatry
Description	Mental processes
Disorders	Mental and behavioral ADHD OCD Tourette's Mood Developmental pervasive dyslexia and specific Substance-related alcohol Emotional and behavioral disorders Symptoms and signs Evaluation and testing
Treatment	Psychotherapy CBT Drugs depression antipsychotics anxiety dementia hypnotics and sedatives

How to manage this template's collapsible groups/sections option

This template includes collapsible groups/sections. When it first appears, one of these groups/sections may be set to be visible ("expanded") while the others remain hidden ("collapsed") apart from their titlebars. To achieve this, include the parameter |name where name is one of the following words that identify the groups/sections (omit any speech or quotation marks):
* "RIEAs", "RARIs", ""TCAs", "MAOIs" or "AZPs"
For example: {{Antidepressants |AZPs}}